Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopenia
Published by Elsevier Inc..
OBJECTIVE: Characterize autoantibodies and autoimmune diseases in a prospective cohort of patients with Idiopathic CD4 Lymphocytopenia (ICL) a rare immunodeficiency characterized by an absolute CD4+ T count of <300 cells/μl in the absence of HIV or HTLV infection.
METHODS: Single-Center prospective study of 67 patients conducted over an 11-year period. Rheumatologic evaluation and measurement of autoantibodies were systematically conducted, and flow cytometry of immune cell subsets was performed in a subset of patients.
RESULTS: 54% of referred patients had clinical evidence of autoimmunity, with 34% having at least one autoimmune disease, most commonly autoimmune thyroid disease. 19%, had autoantibodies or incomplete features of autoimmune disease. Patients with autoimmune disease had more elevated serum immunoglobulins, and more effector memory T cells than those without autoimmunity.
CONCLUSIONS: Evidence of autoimmunity, including autoimmune diseases, is more prevalent in ICL than the general population, and should be considered part of this syndrome.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:224 |
---|---|
Enthalten in: |
Clinical immunology (Orlando, Fla.) - 224(2021) vom: 20. März, Seite 108664 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cudrici, Cornelia D [VerfasserIn] |
---|
Links: |
---|
Themen: |
Autoantibodies |
---|
Anmerkungen: |
Date Completed 11.06.2021 Date Revised 11.06.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.clim.2021.108664 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM319861945 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM319861945 | ||
003 | DE-627 | ||
005 | 20231225172344.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.clim.2021.108664 |2 doi | |
028 | 5 | 2 | |a pubmed24n1066.xml |
035 | |a (DE-627)NLM319861945 | ||
035 | |a (NLM)33422677 | ||
035 | |a (PII)S1521-6616(21)00001-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cudrici, Cornelia D |e verfasserin |4 aut | |
245 | 1 | 0 | |a Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopenia |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.06.2021 | ||
500 | |a Date Revised 11.06.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Published by Elsevier Inc. | ||
520 | |a OBJECTIVE: Characterize autoantibodies and autoimmune diseases in a prospective cohort of patients with Idiopathic CD4 Lymphocytopenia (ICL) a rare immunodeficiency characterized by an absolute CD4+ T count of <300 cells/μl in the absence of HIV or HTLV infection | ||
520 | |a METHODS: Single-Center prospective study of 67 patients conducted over an 11-year period. Rheumatologic evaluation and measurement of autoantibodies were systematically conducted, and flow cytometry of immune cell subsets was performed in a subset of patients | ||
520 | |a RESULTS: 54% of referred patients had clinical evidence of autoimmunity, with 34% having at least one autoimmune disease, most commonly autoimmune thyroid disease. 19%, had autoantibodies or incomplete features of autoimmune disease. Patients with autoimmune disease had more elevated serum immunoglobulins, and more effector memory T cells than those without autoimmunity | ||
520 | |a CONCLUSIONS: Evidence of autoimmunity, including autoimmune diseases, is more prevalent in ICL than the general population, and should be considered part of this syndrome | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Intramural | |
650 | 4 | |a Autoantibody | |
650 | 4 | |a Autoimmunity | |
650 | 4 | |a Idiopathic CD4 lymphocytopenia | |
650 | 4 | |a Opportunistic infections | |
650 | 7 | |a Autoantibodies |2 NLM | |
700 | 1 | |a Boulougoura, Afroditi |e verfasserin |4 aut | |
700 | 1 | |a Sheikh, Virginia |e verfasserin |4 aut | |
700 | 1 | |a Freeman, Alexandra |e verfasserin |4 aut | |
700 | 1 | |a Sortino, Ornella |e verfasserin |4 aut | |
700 | 1 | |a Katz, James D |e verfasserin |4 aut | |
700 | 1 | |a Sereti, Irini |e verfasserin |4 aut | |
700 | 1 | |a Siegel, Richard M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical immunology (Orlando, Fla.) |d 1999 |g 224(2021) vom: 20. März, Seite 108664 |w (DE-627)NLM098196855 |x 1521-7035 |7 nnns |
773 | 1 | 8 | |g volume:224 |g year:2021 |g day:20 |g month:03 |g pages:108664 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clim.2021.108664 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 224 |j 2021 |b 20 |c 03 |h 108664 |